Atossa Therapeutics
ATOS
#10745
Rank
A$29.75 M
Marketcap
A$2.98
Share price
2.55%
Change (1 day)
146.58%
Change (1 year)

EPS for Atossa Therapeutics (ATOS)

EPS in 2026 (TTM): A-$6.06

According to Atossa Therapeutics's latest financial reports the company's current EPS (TTM) is A-$6.07. In 2025 the company made an earnings per share (EPS) of A-$5.99 a decrease over its 2024 EPS that were of A-$4.51.

EPS history for Atossa Therapeutics from 2010 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$6.061.05%
2025A-$5.9932.89%
2024A-$4.51-15.56%
2023A-$5.3414.29%
2022A-$4.6716.67%
2021A-$4.01-90.86%
2020A-$43.84-2.96%
2019A-$45.17-63.09%
2018A-$122.39-49.63%
2017A-$243.00-57.87%
2016A-$576.79-74.01%
2015A-$2,219-9.18%
2014A-$2,443-12.86%
2013A-$2,80470.73%
2012A-$1,64234.07%
2011A-$1,225263.41%
2010A-$337.05

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$9.91-263.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
A$15.10-348.90%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
A$18.20-400.00%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
A-$0.37-93.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
A-$0.31-94.87%๐Ÿ‡บ๐Ÿ‡ธ USA